Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Insight Molecular Diagnostics (IMDX) Debt Ratio (2020 - 2025)

Insight Molecular Diagnostics' Debt Ratio history spans 6 years, with the latest figure at 0.02 for Q3 2025.

  • For Q3 2025, Debt Ratio rose 174.85% year-over-year to 0.02; the TTM value through Sep 2025 reached 0.02, up 174.85%, while the annual FY2024 figure was 0.01, 78.97% down from the prior year.
  • Debt Ratio for Q3 2025 was 0.02 at Insight Molecular Diagnostics, up from 0.01 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.03 in Q4 2023 and bottomed at 0.0 in Q3 2022.
  • The 5-year median for Debt Ratio is 0.01 (2025), against an average of 0.01.
  • The largest annual shift saw Debt Ratio plummeted 93.05% in 2022 before it skyrocketed 2737.24% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 0.01 in 2021, then plummeted by 86.77% to 0.0 in 2022, then surged by 2737.24% to 0.03 in 2023, then tumbled by 78.97% to 0.01 in 2024, then skyrocketed by 269.8% to 0.02 in 2025.
  • Per Business Quant, the three most recent readings for IMDX's Debt Ratio are 0.02 (Q3 2025), 0.01 (Q2 2025), and 0.01 (Q1 2025).